1. Home
  2. HALO vs FLS Comparison

HALO vs FLS Comparison

Compare HALO & FLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • FLS
  • Stock Information
  • Founded
  • HALO 1998
  • FLS 1790
  • Country
  • HALO United States
  • FLS United States
  • Employees
  • HALO N/A
  • FLS N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • FLS Fluid Controls
  • Sector
  • HALO Health Care
  • FLS Industrials
  • Exchange
  • HALO Nasdaq
  • FLS Nasdaq
  • Market Cap
  • HALO 7.4B
  • FLS 8.3B
  • IPO Year
  • HALO N/A
  • FLS N/A
  • Fundamental
  • Price
  • HALO $50.23
  • FLS $52.11
  • Analyst Decision
  • HALO Buy
  • FLS Strong Buy
  • Analyst Count
  • HALO 9
  • FLS 9
  • Target Price
  • HALO $63.78
  • FLS $64.11
  • AVG Volume (30 Days)
  • HALO 2.6M
  • FLS 1.8M
  • Earning Date
  • HALO 05-06-2025
  • FLS 04-29-2025
  • Dividend Yield
  • HALO N/A
  • FLS 1.60%
  • EPS Growth
  • HALO 55.40
  • FLS 20.22
  • EPS
  • HALO 3.76
  • FLS 2.14
  • Revenue
  • HALO $1,084,306,000.00
  • FLS $4,614,870,000.00
  • Revenue This Year
  • HALO $24.79
  • FLS $6.43
  • Revenue Next Year
  • HALO $22.65
  • FLS $3.77
  • P/E Ratio
  • HALO $13.36
  • FLS $24.46
  • Revenue Growth
  • HALO 25.64
  • FLS 4.23
  • 52 Week Low
  • HALO $41.28
  • FLS $37.34
  • 52 Week High
  • HALO $70.51
  • FLS $65.08
  • Technical
  • Relative Strength Index (RSI)
  • HALO 34.42
  • FLS 69.85
  • Support Level
  • HALO $58.38
  • FLS $46.34
  • Resistance Level
  • HALO $69.94
  • FLS $47.89
  • Average True Range (ATR)
  • HALO 3.30
  • FLS 1.37
  • MACD
  • HALO -0.27
  • FLS 0.98
  • Stochastic Oscillator
  • HALO 9.30
  • FLS 96.73

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About FLS Flowserve Corporation

Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. In addition, Flowserve has a network of Quick Response Centers to provide aftermarket equipment services. The aftermarket services help customers with installation, diagnostics, repair, and retrofitting. Sales are roughly split across many regions, with North America and Europe contributing the majority of total revenue.

Share on Social Networks: